ODF4: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

Target Name: ODF4

NCBI ID: G146852

ODF4

ODF4: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

ODF4 (Open Reading Frame 4) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and several studies have shown promise in using ODF4 as a therapeutic approach.

ODF4 is a part of the Open Reading Frame (ORF) family, which is a common framework used to identify and study RNA molecules. ORFs are short regions of DNA that are usually transcribed into RNA and contain a conserved core structure that includes a conserved core sequence, a variable start codon, and a variable stop codon. ODF4 is a non-coding ORF molecule that is expressed in various cell types and has been shown to play a role in regulating gene expression.

One of the key features of ODF4 is its ability to interact with other proteins and molecules. This interaction has led to the identification of ODF4 as a potential drug target and biomarker. ODF4 has been shown to interact with several protein partners, including the transcription factor, activator protein, and protein kinase. These interactions have been shown to play a role in regulating gene expression and influencing cellular processes such as cell growth, apoptosis, and inflammation.

In addition to its potential as a drug target, ODF4 has also been identified as a potential biomarker for several diseases. For example, several studies have shown that ODF4 is downregulated in various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. This downregulation has been shown to play a role in the development and progression of these diseases. Therefore, ODF4 has been identified as a promising biomarker for these diseases and may be a target for future therapeutic approaches.

Another potential use of ODF4 as a drug target is its ability to modulate cellular signaling pathways. ODF4 has been shown to play a role in several signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. These signaling pathways are involved in a variety of cellular processes, including cell growth, apoptosis, and inflammation. Therefore, ODF4 has been shown to be a potential drug target for diseases that are characterized by inflammation and cellular signaling abnormalities.

In conclusion, ODF4 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function have made it an attractive target for researchers to investigate, and several studies have shown promise in using ODF4 as a therapeutic approach. Further research is needed to fully understand the role of ODF4 in disease and to develop safe and effective therapeutic approaches based on ODF4.

Protein Name: Outer Dense Fiber Of Sperm Tails 4

Functions: Component of the outer dense fibers (ODF) of spermatozoa which could be involved in sperm tail structure, sperm movement and general organization of cellular cytoskeleton

The "ODF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ODF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets